Biobanking of Cerebrospinal Fluid for Biomarker Analysis in Neurological Diseases
- 1 January 2015
- book chapter
- Published by Springer Nature
- Vol. 864, 79-93
Abstract
Cerebrospinal fluid (CSF) reflects pathophysiological aspects of neurological diseases, where neuroprotective strategies and biomarkers are urgently needed. Therefore, biobanking is very relevant for biomarker discovery and evaluation for these neurological diseases. An important aspect of CSF biobanking is quality control, needed for e.g. consistent patient follow-up and the exchange of patient samples between research centers. Systematic studies to address effects of pre-analytical and storage variation on a broad range of CSF proteins are needed and initiated. Important features of CSF biobanking are intensive collaboration in international networks and the tight application of standardized protocols. The current adoption of standardized protocols for CSF and blood collection and for biobanking of these samples, as presented in this chapter, enables biomarker studies in large cohorts of patients and controls. In conclusion, biomarker research in neurodegenerative diseases has entered a new era due to the collaborative and multicenter efforts of many groups. The streamlining of biobanking procedures, including sample collection, quality control, and the selection of optimal control groups for investigating biomarkers is an important improvement to perform high quality biomarker studies.Keywords
This publication has 75 references indexed in Scilit:
- Neuroprotein Dynamics in the Cerebrospinal Fluid: Intraindividual Concomitant Ventricular and Lumbar MeasurementsEuropean Neurology, 2013
- Characterization of Acid Sphingomyelinase Activity in Human Cerebrospinal FluidPLOS ONE, 2013
- Cerebrospinal Fluid Aβ and Tau Level Fluctuation in an Older Clinical CohortArchives of Neurology, 2012
- Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALSAmyotrophic Lateral Sclerosis, 2012
- Phytocannabinoids, CNS cells and development: A dead issue?Drug and Alcohol Review, 2010
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobankingNeurology, 2009
- Serum biobank certification and the establishment of quality controls for biological fluids: examples of serum biomarker stability after temperature variationClinical Chemistry and Laboratory Medicine (CCLM), 2007
- Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the ratLife Sciences, 2006
- ZNS-Proteine im Liquor: Einflussfaktoren auf ihre Konzentration im Liquor und klinische Relevanz Brain specific proteins in cerebrospinal fluid (CSF): factors influencing their concentration in CSF and clinical relevanceJournal of Laboratory Medicine, 2005
- The impact of blood contamination on the proteome of cerebrospinal fluidProteomics, 2005